Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes Mellitus

• Status: Completed
• Trial end date: 2017-05-01

Summary

Study whether SLC30A8 rs13266634 polymorphism is associated with type 2 diabetes mellitus (T2DM) susceptibility in Egyptian patients and study effect of Zn supplementation on glycemic control in patients with type 2 diabetes

• Phase: Phase 4

Details

• Lead Sponsor: Cairo University
• Treatments: Retinol palmitate; Vitamin A; Vitamins; Zinc